Biocytogen provides one-stop solutions for next-generation drug development, from target to IND application to the global biomedical communities. Powered by its cutting-edge gene editing technologies and state-of-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery. The technical teams in Biocytogen support a comprehensive portfolio of products and services, covering in vivo/in vitro preclinical services, animal model generation, fully human antibody (via RenMab™ Mouse), therapeutic antibody discovery services, CMC/CDMO, and regulatory affairs support. Biocytogen collaborates with more than 70% of top 50 pharmaceutical and numerous biotech start-up companies worldwide. Together, we discover innovative medicines for a better, healthier world.
Site |
Badges |
|
BIOCYTOGEN BEIJING; Biocytogen Pharmaceuticals (Beijing) Co., Ltd.,
No. 12, Baoshen South Street
Daxing, Beijing, 102609
China
|
|
|
BIOCYTOGEN HAIMEN Jiangsu Co., Ltd.,
Building #12
Linjiang New District, Haimen Jiangsu Province, 226100
China
|
|
|
Biocytogen Boston Corp.
300 3rd Ave
Waltham, MA, 02451
United States
|
|